Dedicated to Advancing the Clinical & Commercial Success of
Exosome Based Therapeutics

The exosome and EV-therapeutics industry is full of anticipation as the first few companies to reach clinical trials prepare to move ahead. As scientific understanding continues to grow and manufacturing methods constantly being fine-tuned, it’s now all about developing effective therapies to be the first to market.

 

The 2nd Digital Exosome Based Therapeutic Development Summit will unite pharma, biotech, academic and technology providers to accelerate the discovery, development and commercialization of safe and effective exosome-based therapeutics. Focusing exclusively on evidence-based therapeutic applications, this summit helps industry leaders and newcomers alike overcome key challenges to improve end-to-end development, inform therapeutic decision-making and progress robust pipelines in this exciting field.

 

Thank you to our speakers, sponsors and delegates who joined us for the online summit! If you are interested in the 2021 event, please get in touch as info@hansonwade.com

Why Attendees Joined the 2020 event?

If you are exploring the therapeutic applications of exosomes in an evidence-based approach, this is the place for you.

 

This digital program is tailor-made to meet the industry’s biggest challenges, including scalable manufacturing, characterization, purification, cargo loading, understanding underlying mechanisms, and much more to empower teams to deliver GMP-grade targeted therapeutics.

 

Bringing together leading teams and newcomers alike, this conversation isn’t one to be missed.

2020 Featured Speakers

Proud To Partner In 2020 With